跳至主要内容
临床试验/EUCTR2005-004012-78-AT
EUCTR2005-004012-78-AT进行中(未招募)1 期

Effects of acarbose on endothelial function, platelet activity, insulin sensitivity and glucose control in subjects with coronary artery disease and new onset type-II diabetes.

Medical University of Graz0 个研究点目标入组 56 人开始时间: 2005年11月11日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age 40-70 years
  • Angiographically verified coronary artery disease (> 50 % stenosis)
  • Diabetic oGTT at the occasion of angiography
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Acute coronary syndrome or cerebrovascular event within the previous 8 weeks
  • Acetylsalicylic acid at a dose > 100 mg daily
  • Any other NSAID or antiplatelet drug
  • BMI > 35 kg/m2
  • HbA1c > 7.5 %
  • Serum creatinine > 2.5 mg/dl
  • GOT/GPT > 3x upper limit of normal
  • Heart failure > class NYHA II
  • Uncontrolled hypertension (blood pressure > 165 / 100 mmHg)
  • New onset statin or ACE-inhibitor within the previous 8 weeks
  • Known intolerance of acarbose
  • Chronic inflammatory bowel disease
  • Malabsorption syndromes
  • any antidiabetic medication

研究者

发起方
Medical University of Graz

相似试验